Skip to content

PTHS PTHS Quick ratio

Quick ratio at other companies

Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
0.7×-0.2×
Scilex Holding Company logo
Scilex Holding CompanySCLX
0.1×0.0×
Journey Medical Corporation logo
Journey Medical CorporationDERM
1.5×+0.4×
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
4.9×+2.3×
Opko Health logo
Opko HealthOPK
3.2×+0.9×
Theravance Biopharma logo
Theravance BiopharmaTBPH
13.1×+8.4×

Other financials

Income statement

See full
Revenue$10.9M
Gross profit$9.2M
Operating income-$13.1M-614%
Net income-$10.2M-420%
EPS (diluted)-$3.09+3.7%

Balance sheet

See full
Cash & equivalents$32.0M+24,250%
Total debt$29.6M
Total equity$35.1M+937%
Total assets$145.4M+15,855%

Cash flow

See full
Operating cash flow-$13.1M-1,977%
CapEx$194.0K
Free cash flow-$13.3M-2,008%

Valuation

See full
Market cap$98.22M+75.4%
Enterprise value$95.89M
P/S3.6×

Profitability

See full
Gross margin79.6%
Operating margin-157.7%
Net margin-186.2%
FCF margin-60.8%

Returns & leverage

See full
Return on equity-333.8%
Debt / equity0.8×
Current ratio2.8×+2.6×

Where this comes from

Calculated from PTHS’s reported figures.

Based on the most recent quarter.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTHS's quick ratio?
PTHS (PTHS) reported quick ratio of 1.9× in Q1 2026.
How has PTHS's quick ratio changed year-over-year?
PTHS's quick ratio increased by 939.9% year-over-year, from 0.2× to 1.9×.
What is the long-term trend for PTHS's quick ratio?
Over 3 years (2022 to 2025), PTHS's quick ratio has grown at a 328.4% compound annual growth rate (CAGR), from 0× to 1.1×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.